Medicus Pharma Ltd. (MDCX): Total Liabilities
$10.02M
As of 2025-12-31
$28.84M
As of 2026-06-30
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $10.02M | +299.0% | 2026-03-25, Balance as of period end |
| 2024-12-31 | $2.51M | +221.4% | 2026-03-25, Balance as of period end |
| 2023-12-31 | $781.6K | n/a | 2025-03-28, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| Medicus Pharma Ltd. (MDCX) | 2025-12-31 | $10.02M | +299.0% |
| Oragenics Inc (OGEN) | 2025-12-31 | $1.79M | +6.1% |
| Genprex, Inc. (GNPX) | 2025-12-31 | $2.20M | -12.3% |
| Lunai Bioworks Inc. (LNAI) | 2026-06-30 | $18.97M | -35.9% |
| Nanoviricides, Inc. (NNVC) | 2026-06-30 | $1.20M | -7.7% |
| Longeveron Inc. (LGVN) | 2025-12-31 | $4.59M | +24.9% |
| Cocrystal Pharma, Inc. (COCP) | 2025-12-31 | $3.38M | -14.0% |
| MAIA Biotechnology, Inc. (MAIA) | 2025-12-31 | $7.33M | +12.4% |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | 2025-12-31 | $8.22M | +357.5% |
Compare MDCX, OGEN, GNPX, LNAI side by side · Screen every company in Pharmaceutical Preparations ↗